Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse

Published:2017-01-23 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Blazevic Amir,Hummer Alfred A.,Heffeter Petra,Berger Walter,Filipits Martin,Cibin Giannantonio,Keppler Bernhard K.,Rompel Annette

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep40966.pdf

Reference44 articles.

1. Jakupec, M. A., Galanski, M., Arion, V. B., Hartinger, C. G. & Keppler, B. K. Antitumour metal compounds: more than theme and variations. Dalton Trans. 2, 183–194, doi: 10.1039/b712656p (2008).

2. Heffeter, P. et al. Intrinsic and Acquired Forms of Resistance against the Anticancer Ruthenium Compound KP1019 [Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A). J. Pharmacol. Exp. Ther. 312, 281–289, doi: 10.1124/jpet.104.073395 (2005).

3. Heffeter, P. et al. Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339. JBIC, J. Biol. Inorg. Chem. 15, 737–748, doi: 10.1007/s00775-010-0642-1 (2010).

4. Hartinger, C. G., Phillips, A. D. & Nazarov, A. A. Polynuclear ruthenium, osmium and gold complexes. The Quest for Innovative Anticancer Chemotherapeutics. Curr. Top. Med. Chem. 11, 2688–2702, doi: 10.2174/156802611798040769 (2011).

5. Lipponer, K. G., Vogel, E. & Keppler, B. K. Synthesis, characterization and solution chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a new anticancer ruthenium complex. IR, UV, NMR, HPLC investigations and antitumor activity. Crystal structures of trans-1-Methyl-Indazoliumtetrachlorobis-(1-Methylindazole)Ruthenate(III) and its hydrolysis product trans-Monoaquatrichlorobis-(1-Methylindazole)-Ruthenate(III). Met.-based drugs 3, 243–260, doi: 10.1155/MBD.1996.243 (1996).

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metals in Cancer Research: Beyond Platinum Metallodrugs;ACS Central Science;2024-02-07

2. Illuminating the future: a review of ruthenium-based agents for dual action photochemotherapy and photodynamic therapy;Photochemistry;2023-12-20

3. Rational synthesis of ruthenium-based metallo-supramolecular polymers as heterogeneous catalysts for catalytic transfer hydrogenation of carbonyl compounds;Applied Catalysis B: Environmental;2022-09

4. Challenges and opportunities in the development of metal-based anticancer theranostic agents;Bioscience Reports;2022-05

5. Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics;Pharmaceutics;2022-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3